← Back to Clinical Trials
Recruiting Phase 2, Phase 3 NCT05605704
Olive Leaf Extracts in the Control of Diabet
Trial Parameters
Condition Diabetes Mellitus, Type 2
Sponsor University of Monastir
Study Type INTERVENTIONAL
Phase Phase 2, Phase 3
Enrollment 500
Sex ALL
Min Age 18 Years
Max Age 100 Years
Start Date 2023-01-01
Completion 2025-09-15
Interventions
AtherolivePlacebo Atherolive
Brief Summary
This study will be carried out in 2 emergency departments (at the exit of the emergency room) and 2 external consultations (endocrinology of the CHU FB Monastir and diabetology consultation, Jemmal hospital). Patients over 18 years of age with: -Diabets
Eligibility Criteria
Inclusion Criteria: * Patients over 18 years of age with: * diabetes. Exclusion Criteria: * Exclusion criteria: None.